Facebook
X
LinkedIn
ForwardJanuary 15th, 2026: Defining and Risk-stratifying MASLD/MASH
Welcome to the first session of this ECHO program!
Claiming Credit
Thank you for attending the session on January 15, 2026. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to claim your credit on the following page
Target Audience
This ECHO® series is designed for a primary care audience. It is open to physicians, nurse practitioners (NPs), physician associates (PAs), and nurses who care for people with MASLD/MASH.
Learning Objectives:
At the conclusion of this learning activity, participants will be better able to:
- Define the conditions of MASLD and MASH and their relationship to cardiometabolic conditions such as obesity and type 2 diabetes.
- Integrate available non-invasive tests into clinical practice for the identification, risk-stratification, and monitoring of patients with MASLD/MASH.
- Identify emerging treatments for MASLD/MASH and the criteria for patient eligibility.
- Outline evidence-based management strategies for individuals with MASLD/MASH, including how available therapies (e.g., GLP-1 RAs) can target multiple disease mechanisms.
Grantor Acknowledgement:
This activity is supported by an educational grant from Novo Nordisk Inc.
Arpan Mohanty, MD, MSc
Program Course Director
Staff Hepatologist,
Director of Clinical Research in Gastroenterology
Boston Medical Center
Assistant Professor of Medicine,
Boston University Chobanian & Avedisian School of Medicine
Boston, MA
Arpan Mohanty, MD, MSc is a hepatologist and clinical researcher at Boston Medical Center and Assistant Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine, where she directs Clinical Research in the Section of Gastroenterology. Her work focuses on improving care delivery for chronic liver diseases and has been supported by the NIH, AASLD, and RSNA. A recipient of the Robert A. Winn Career Development Award, she leads multiple clinical trials in chronic liver diseases and serves on the AASLD Practice Guidelines Committee. Dr. Mohanty is board certified in Internal Medicine, Gastroenterology, and Transplant Hepatology.
Dr. Mohanty is on the advisory board and receives grant research support from Gilead. She is also on the advisory board for Takeda and is a consultant and on the Adjudication Committee for Medpace. She is a consultant for Novo Nordisk and receives grant research support from Inventiva. She also serves as the site PI for clinical trials for Atea, Inventiva, Kowa, Madrigal, Novo Nordisk, and Takeda.
Disclosure Policy:
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.
Accreditation Statement
This activity is developed by Boston University Chobanian & Avedisian School of Medicine.
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Accreditation
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Please note that 4.0 credits are based on participation in all four ECHO® sessions.
Family Practitioner Accreditation
The AAFP has reviewed ECHOing Excellence: MASLD/MASH Made Manageable in Primary Care and deemed it acceptable for AAFP credit. Term of approval is from 01/15/2026 to 01/15/2027. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This session ECHOing Excellence: MASLD/MASH Made Manageable in Primary Care is approved for 1.0 online AAFP Prescribed credits.
American Board of Internal Medicine Maintenance of Certification (MOC) Part 2 Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By participating and claiming credit, you agree to BU sharing your information with ACCME PARS the data conduit to the ABIM.
Please note that 4.0 credits are based on participation in all four ECHO® sessions.
Nurse Accreditation
Nursing Contact Hours: 4.0, of which 4.0 are eligible for pharmacology credit.
Please note that 4.0 credits are based on participation in all four ECHO® sessions.
Physician Associate Accreditation
Boston University Chobanian & Avedisian School of Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Please note that 4.0 credits are based on participation in all four ECHO® sessions.
Questions: If you have any questions about the program, registering or claiming credit please write [email protected] and your questions will be answered.
Available Credit
- 1.00 AAPA Category I CME
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 ANCC
- 1.00 Participation